Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure
- 1 April 2010
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 12 (2) , 127-131
Abstract
We report 2 cases of severe pneumonia due to the novel pandemic influenza A/H1N1 2009 in kidney transplant recipients. Our patients initially experienced influenza-like illness that rapidly progressed to severe pneumonia within 48 h. The patients became hypoxic and required non-invasive ventilation. The novel influenza A/H1N1 2009 was identified from their nasal swabs. These cases were treated successfully with a relatively high dose of oseltamivir, adjusted for their renal function. Clinical improvement was documented only after a week of antiviral therapy. Despite early antiviral treatment, we showed that morbidity following novel pandemic influenza A/H1N1 2009 infection is high among kidney transplant recipients.Keywords
This publication has 15 references indexed in Scilit:
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoNew England Journal of Medicine, 2009
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and MiceScience, 2009
- Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in FerretsScience, 2009
- Pathology of human influenza revisitedVaccine, 2008
- Histopathologic and Immunohistochemical Features of Fatal Influenza Virus Infection in Children during the 2003–2004 SeasonClinical Infectious Diseases, 2006
- The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysisNephrology Dialysis Transplantation, 2006
- Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)Veterinary Pathology, 2003
- Safety and Pharmacology of Oseltamivir in Clinical UseDrug Safety, 2003
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999